Clinical Trial Update: Adjuvant Hepatic Arterial Infusional Chemotherapy After Curative Resection of Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating adjuvant hepatic arterial infusion chemotherapy after curative resection of hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Yonsei University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: COMPLETED